Banner

H1N1 Vaccine Global Market Report 2023 – By Product Type (Inactivated Vaccine, Live Attenuated Vaccine), By Route Of Administration (Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination), By End Users (Hospitals, Clinics, Research and Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 200 | Published : January 2023 | SKU CODE : | Delivery Time: 2-3 business days | Format :


H1N1 vaccines are administered to people six months of age and older to immunize them against influenza diseases brought on by the H1N1 2009 virus. These are used to prevent humans from Influenza virus infection by injecting a small dose of the virus inside the body to build immunity against the virus.

The main product types of H1N1 vaccine are inactivated vaccine, and live attenuated vaccine. The inactivated vaccine market consists of sales of H1N1 vaccine products that are used to prevent disease caused by the influenza H1N1 virus. Inactivated vaccine is a synthetic vaccine with protective immunising action that contains hemagglutinin (HA) antigens generated from four inactivated influenza viruses, including two different influenza type. A strains and two different influenza type B strains. The various routes of administration include intradermal vaccination, intramuscular vaccination, and subcutaneous vaccination which are used by various end users such as hospitals, clinics, research and diagnostic laboratories, and others.

The H1N1 vaccine report is one of a series of new reports from The Business Research Company that provides H1N1 vaccine statistics, including H1N1 vaccine industry global market size, regional shares, competitors with an H1N1 vaccine share, detailed H1N1 vaccine segments, market trends and opportunities, and any further data you may need to thrive in the H1N1 vaccine industry. This H1N1 vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global H1N1 vaccine market size is expected to grow from $2.94 billion in 2022 to $3.14 billion in 2023 at a compound annual growth rate (CAGR) of 7.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The H1N1 vaccine market size is expected to grow to $4.04 billion in 2027 at a CAGR of 6.5%.

The increase in expenditure for research and development activities in the field of immunology and vaccine is expected to propel the growth of the H1N1 vaccine market going forward. Immunology and vaccines are used to prevent infections and help in producing antibodies to fight infections. Immunology is a crucial area of research in the medical and biological sciences that focuses on understanding the immune system. The H1N1 vaccine is a preparation used to boost antibody production, which provides immunity against a variety of diseases. For instance, according to an article by the kENUP Foundation, a Europe-based non-profit supporting research-based innovation in health industries, in January 2021, governments spent at least $94.11 billion (€93 billion) on the development of vaccines and treatments since the start of the pandemic worldwide. The public sector committed 95% of the total spending, or $87.54 billion (€86.5 billion), in just 11 months to the development of vaccinations. Therefore, increasing expenditure for research and development activities in the field of immunology and vaccines is driving the growth of the H1N1 vaccine market.

An upsurge in the spread of H1N1 infection is expected to propel the growth of the H1N1 vaccine market going forward. H1N1 influenza refers to a subtype of influenza A virus, a communicable viral illness that causes upper and, in some cases, lower respiratory tract infections in its host. The H1N1 vaccine should be administered as a single 0.5-mL intramuscular injection that helps to prevent infection caused by influenza A (H1N1). Also, helps the body produce its own antibodies against the disease. For instance, according to the Times of India, an India-based daily newspaper, as of August 2022, nearly H1N1 influenza 1,500 cases and 43 deaths have been reported in Maharashtra in the year 2022. Further, according to the Center for Disease Control and Prevention, a US-based government health organization, in October 2021, there were 1,35,046 people tested positive for influenza out of 35,47,791 tests, out of which 1,32,809 were affected by influenza A and 2,237 were affected by influenza B. Therefore, an upsurge in the spread of H1N1 infection is driving the growth of the H1N1 vaccine market.

Strategic collaborations between companies is a key trend that is gaining popularity in the H1N1 (swine flu) vaccination market. Companies in the H1N1 (swine flu) Vaccination market are focusing on strategic collaborations to expand their market share. For instance, in August 2022, A significant, a pharmaceutical company and Open Orphan affiliate hVIVO have agreed to an agreement for $123 million to create a brand-new batch of H1N1 influenza challenge virus. This has stimulated the growth potential of both companies in the industry.

Major players in the H1N1 vaccine market are Sanofi, Novartis AG, GlaxoSmithKline plc, CSL Limited, AstraZeneca, Zydus Cadila, Merck and Co. Inc., NovavaxInc., Baxter, Panacea Biotec Ltd., Sinovac Biotech Ltd., Green Cross Corp., Abbott, Pfizer Inc., Mitsubishi Tanabe Pharma Corporation., Seqirus, and Cipla Inc.

North America was the largest region in the H1N1 vaccine market in 2022. The regions covered in the H1N1 vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the H1N1 vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and the USA.

The H1N1 vaccines market consists of sales of TIV (flu shot (injection) and LAIV (nasal spray (mist) of live attenuated influenza vaccine). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

 

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global H1N1 vaccine market is segmented -

1) By Product Type: Inactivated Vaccine, Live Attenuated Vaccine

2) By Route Of Administration: Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination

3) By End Users: Hospitals, Clinics, Research and Diagnostic Laboratories, Other End Users

    Table Of Contents

    1. Executive Summary

    2. H1N1 Vaccine Market Characteristics

    3. H1N1 Vaccine Market Trends And Strategies

    4. H1N1 Vaccine Market - Macro Economic Scenario

    4.1. COVID-19 Impact On H1N1 Vaccine Market

    4.2. Ukraine-Russia War Impact On H1N1 Vaccine Market

    4.3. Impact Of High Inflation On H1N1 Vaccine Market

    5. H1N1 Vaccine Market Size And Growth

    5.1. Global H1N1 Vaccine Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global H1N1 Vaccine Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. H1N1 Vaccine Market Segmentation

    6.1. Global H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Inactivated Vaccine

    Live Attenuated Vaccine

    6.2. Global H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Intradermal Vaccination

    Intramuscular Vaccination

    Subcutaneous Vaccination

    6.3. Global H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospitals

    Clinics

    Research and Diagnostic Laboratories  

    Other End Users

    7. H1N1 Vaccine Market Regional And Country Analysis

    7.1. Global H1N1 Vaccine Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global H1N1 Vaccine Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific H1N1 Vaccine Market  

    8.1. Asia-Pacific H1N1 Vaccine Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China H1N1 Vaccine Market  

    9.1. China H1N1 Vaccine Market Overview  

    9.2. China H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India H1N1 Vaccine Market  

    10.1. India H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan H1N1 Vaccine Market  

    11.1. Japan H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia H1N1 Vaccine Market  

    12.1. Australia H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia H1N1 Vaccine Market  

    13.1. Indonesia H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea H1N1 Vaccine Market  

    14.1. South Korea H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe H1N1 Vaccine Market  

    15.1. Western Europe H1N1 Vaccine Market Overview

    15.2. Western Europe H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK H1N1 Vaccine Market  

    16.1. UK H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany H1N1 Vaccine Market  

    17.1. Germany H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France H1N1 Vaccine Market  

    18.4. France H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe H1N1 Vaccine Market  

    19.1. Eastern Europe H1N1 Vaccine Market Overview

    19.2. Eastern Europe H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia H1N1 Vaccine Market  

    20.1. Russia H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America H1N1 Vaccine Market  

    21.1. North America H1N1 Vaccine Market Overview

    21.2. North America H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA H1N1 Vaccine Market  

    22.1. USA H1N1 Vaccine Market Overview

    22.2. USA H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America H1N1 Vaccine Market  

    23.1. South America H1N1 Vaccine Market Overview

    23.2. South America H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil H1N1 Vaccine Market  

    24.1. Brazil H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East H1N1 Vaccine Market  

    25.1. Middle East H1N1 Vaccine Market Overview

    25.2. Middle East H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa H1N1 Vaccine Market  

    26.1. Africa H1N1 Vaccine Market Overview

    26.2. Africa H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. H1N1 Vaccine Market Competitive Landscape And Company Profiles

    27.1. H1N1 Vaccine Market Competitive Landscape

    27.2. H1N1 Vaccine Market Company Profiles

    27.2.1. Sanofi

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Novartis AG

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. GlaxoSmithKline plc

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. CSL Limited

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. AstraZeneca

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The H1N1 Vaccine Market

    29. H1N1 Vaccine Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global H1N1 Vaccine Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global H1N1 Vaccine Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: China, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: India, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: Japan, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Australia, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Indonesia, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: South Korea, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Western Europe, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: UK, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Germany, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: France, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Eastern Europe, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Russia, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: North America, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: USA, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: South America, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: Brazil, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Middle East, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Africa, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Sanofi Financial Performance
  • Table 47: Novartis AG Financial Performance
  • Table 48: GlaxoSmithKline plc Financial Performance
  • Table 49: CSL Limited Financial Performance
  • Table 50: AstraZeneca Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global H1N1 Vaccine Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global H1N1 Vaccine Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: China, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: India, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: Japan, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Australia, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Indonesia, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: South Korea, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Western Europe, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: UK, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Germany, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: France, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Eastern Europe, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Russia, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: North America, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: USA, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: South America, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: Brazil, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Middle East, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Africa, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Sanofi Financial Performance
  • Figure 47: Novartis AG Financial Performance
  • Figure 48: GlaxoSmithKline plc Financial Performance
  • Figure 49: CSL Limited Financial Performance
  • Figure 50: AstraZeneca Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report